The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

Retinopathy of prematurity occurs because the retina of a preterm infant at birth is incompletely vascularized, and if the postnatal environment does not match the in utero environment that supported retinal development, the vessels and neural retina will not grow normally. Risk factors determined from many clinical studies and animal studies fall into 2 categories: prenatal factors and postnatal factors.

• Publication year

  2013

• Venue

  Clinics of Perinatology

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.clp.2013.02.002PMID 23719305PMCID PMC3673697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extreme Prematurity and Fibroblastic Overgrowth of Persistent Vascular Sheath Behind Each Crystalline Lens: I. Preliminary report.

  2018cited by this paper
• Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2014cited by this paper
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes

  2013cited by this paper
• Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity.

  2012cited by this paper
• Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants.

  2012cited by this paper
• Aggressive posterior retinopathy of prematurity in large preterm babies in South India

  2012cited by this paper
• A predictive score for retinopathy of prematurity in very low birth weight preterm infants

  2012cited by this paper
• Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity.

  2012cited by this paper
• 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids

  2011cited by this paper
• [The early postnatal weight gain as a predictor of retinopathy of prematurity].

  2011cited by this paper
• Increased 36 week survival with high oxygen saturation target in extremely preterm infants

  2011cited by this paper
• A Clinical Prediction Model to Stratify Retinopathy of Prematurity Risk Using Postnatal Weight Gain

  2011cited by this paper
• Maternal and neonatal factors associated with poor early weight gain and later retinopathy of prematurity

  2011cited by this paper
• High or Low Oxygen Saturation and Severe Retinopathy of Prematurity: A Meta-analysis

  2010cited by this paper
• Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.

  2010cited by this paper
• Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina

  2010cited by this paper
• Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity.

  2010cited by this paper
• Natural history of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden.

  2010cited by this paper
• Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP.

  2010cited by this paper
• Early Weight Gain Predicts Retinopathy in Preterm Infants: New, Simple, Efficient Approach to Screening

  2009cited by this paper
• Oxygen-Induced Retinopathy in Mice: Amplification by Neonatal IGF-I Deficit and Attenuation by IGF-I Administration

  2009cited by this paper
• Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

  2009cited by this paper
• Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF‐1α and VEGF

  2009cited by this paper
• Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

  2009cited by this paper
• Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.

  2009cited by this paper
• Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.

  2009cited by this paper
• Insulin-like growth factor I concentrations in infancy predict differential gains in body length and adiposity: the Cambridge Baby Growth Study.

  2009cited by this paper
• Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture.

  2008cited by this paper
• Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.

  2008cited by this paper
• INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II

  2008cited by this paper
• In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.

  2008cited by this paper
• Twenty years of childhood blindness: what have we learnt?

  2008cited by this paper
• Erythropoietin deficiency decreases vascular stability in mice.

  2008cited by this paper
• A double-edged sword: erythropoietin eyed in retinopathy of prematurity.

  2008cited by this paper
• IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth

  2007cited by this paper
• Retinopathy of prematurity

  2007cited by this paper
• Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.

  2007cited by this paper
• Perinatal adaptation in mammals: the impact of metabolic rate.

  2007cited by this paper
• Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

  2007cited by this paper
• Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.

  2006cited by this paper
• Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2006cited by this paper
• Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model.

  2006cited by this paper
• Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California).

  2006cited by this paper
• Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs

  2005cited by this paper
• Erythropoietin as a retinal angiogenic factor.

  2005cited by this paper
• The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study

  2005cited by this paper
• Astrocyte-endothelial cell relationships during human retinal vascular development.

  2004cited by this paper
• Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.

  2003cited by this paper
• Erythropoietin as an angiogenic factor

  2003cited by this paper
• The insulin-like growth factors and feto-placental growth.

  2003cited by this paper
• Animal models of oxygen-induced retinopathy.

  2003cited by this paper
• IGF-I is critical for normal vascularization of the human retina.

  2002cited by this paper
• Erythropoietin and VEGF exhibit equal angiogenic potential.

  2002cited by this paper
• The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

  2001cited by this paper
• Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity

  2001cited by this paper
• Ten-year follow-up from the CRYO-ROP study.

  2001cited by this paper
• Childhood blindness in the context of VISION 2020--the right to sight.

  2001cited by this paper
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

  2000cited by this paper
• Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.

  2000cited by this paper
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

  1999cited by this paper
• Community eye health.

  1999cited by this paper
• [Retinopathy of prematurity].

  1998cited by this paper
• Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.

  1998cited by this paper
• Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome.

  1997cited by this paper
• Essential role of growth hormone in ischemia-induced retinal neovascularization.

  1997cited by this paper
• Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity.

  1997cited by this paper
• Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.

  1996cited by this paper
• Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

  1996cited by this paper
• Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome.

  1996cited by this paper
• Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.

  1996cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis.

  1995cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

  1995cited by this paper
• Oxygen-induced retinopathy in the mouse.

  1994cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1988cited by this paper
• Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally.

  1986cited by this paper
• Retinal vascular development in premature infants.

  1977cited by this paper
• Further observations on cost of preventing retrolental fibroplasia.

  1974cited by this paper
• Experimental Approach to the Pathogenesis of Retrolental Fibroplasia *

  1955cited by this paper
• Effect of Oxygen on Developing Retinal Vessels with Particular Reference to the Problem of Retrolental Fibroplasia

  1954cited by this paper
• Experimental Approach to the Pathogenesis of Retrolental Fibroplasia: I. Changes of the Eye Induced by Exposure of Newborn Mice to Concentrated Oxygen

  1954cited by this paper
• Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations.

  1952cited by this paper
• INTENSIVE OXYGEN THERAPY AS A POSSIBLE CAUSE OF RETROLENTAL FIBROPLASIA: A CLINICAL APPROACH

  1951cited by this paper
• The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases

  1948cited by this paper
• Extreme Prematurity and Fibroblastic Overgrowth of Persistent Vascular Sheath Behind Each Crystalline Lens* : I. Preliminary Report

  1942cited by this paper

• Assessing the Prevalence and Determinants of Retinopathy of Prematurity in King Saud Medical City, Saudi Arabia

  2026cites this paper
• Exposure to Type 1 and Type 2 Maternal Diabetes is Associated with Stage 3-5 Retinopathy of Prematurity

  2026cites this paper
• Non-neuronal cell microenvironment control retinal vascular remodeling by CST3 in the oxygen-induced retinopathy in mice.

  2026cites this paper
• Management of Retinopathy of Prematurity in the United Arab Emirates: A Consensus Statement From the Emirates Society of Ophthalmology

  2026cites this paper
• A review on retinopathy of prematurity

  2025cites this paper
• Retinopathy of prematurity in late preterm and early term neonates: Incidence and risk factors in a prospective cohort.

  2025cites this paper
• Systemic regulation of retinal medium-chain fatty acid oxidation repletes TCA cycle flux in oxygen-induced retinopathy

  2025cites this paper
• Mesenchymal stromal cell extracellular vesicles improve lung development in mechanically ventilated preterm lambs.

  2024cites this paper
• Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside

  2024cites this paper
• β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation

  2024cites this paper
• Nutritional interventions to prevent retinopathy of prematurity

  2024cites this paper
• Timing and Substrate of Enteral Feeding as Risk Factors for Developing Retinopathy of Prematurity

  2024cites this paper
• Melatonin and its bioisosteres as potential therapeutic agents for the treatment of retinopathy of prematurity

  2024cites this paper
• Validation of a Published Model to Reduce Burden of Retinopathy of Prematurity Screening.

  2023cites this paper
• The incidence of retinopathy of prematurity in neonates in Germany in 2019; a nationwide epidemiological cohort study

  2023cites this paper
• Research hotspots and trends in retinopathy of prematurity from 2003 to 2022: a bibliometric analysis

  2023cites this paper
• Primary prevention of ROP: more can be done in all settings

  2023cites this paper
• Retinopathy of prematurity in India – what can we learn from the polio legacy?

  2023cites this paper
• Cord blood transforming growth factor-β-induced as predictive biomarker of retinopathy of prematurity in preterm infants

  2023cites this paper
• Management of retinopathy of prematurity: an updated review

  2022cites this paper
• Markers of Hypoxia and Metabolism Correlate With Cell Differentiation in Retina and Lens Development

  2022influential citation
• The Determinative Role of Cytokines in Retinopathy of Prematurity.

  2022cites this paper
• Applying Lucentis for the treatment of retinopathy of prematurity

  2022cites this paper
• Effect of Optimizing Oxygen Saturation Targets on the Incidence of Retinopathy of Prematurity in a Quaternary NICU

  2022cites this paper
• Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review

  2022cites this paper
• RATE OF AND TIME TO COMPLETE RETINAL VASCULARIZATION IN PREMATURE INFANTS AND ASSOCIATED FACTORS

  2022cites this paper
• The Ambiguous Aspects of Oxygen

  2022cites this paper
• ROP-like retinopathy in full/near-term newborns: A etiology, risk factors, clinical and genetic characteristics, prognosis and management

  2022cites this paper
• Beyond Fetal Immunity: A Systematic Review and Meta-Analysis of the Association Between Antenatal Corticosteroids and Retinopathy of Prematurity

  2022cites this paper
• Care practices and outcomes of extremely preterm neonates born at 22–24 weeks – A single centre experience

  2021cites this paper
• The Incidence of Retinopathy in Preterm Infants with Birthweight Above 1500 Grams Doğum Ağırlığı 1500 Gramın Üstündeki Preterm Yenidoğanlarda Retinopati Sıklığı

  2021cites this paper
• β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo

  2021influential citation
• The Effect of STAT3 Signal Pathway Activation on Retinopathy of Prematurity

  2021cites this paper
• Artificial Intelligence in Retinopathy of Prematurity

  2021cites this paper
• Predicting previable preterm premature rupture of membranes (pPPROM) before 24 weeks: maternal and fetal/neonatal risk factors for survival

  2021cites this paper
• Impairment of endothelium-dependent vasodilator function of retinal blood vessels in adult rats with a history of retinopathy of prematurity.

  2021cites this paper
• IGF1 gene is epigenetically activated in preterm infants with intrauterine growth restriction

  2020cites this paper
• Regulatory Effect of Melatonin on the Proangiogenic Factors in Rat Retina in Experimental Oxygen-Induced Retinopathy

  2020influential citation
• Lung and eye disease develop concurrently in supplemental oxygen-exposed neonatal mice.

  2020cites this paper
• Protective effects of rapamycin on the retinal vascular bed during the vaso‐obliteration phase in mouse oxygen‐induced retinopathy model

  2020cites this paper
• Trends in Retinopathy of Prematurity over 12 Years in a Colorado Cohort

  2020cites this paper
• Anti-angiogenic effect of matrine in in-vivo rop-mouse- model

  2020cites this paper
• Achieved oxygen saturations and retinopathy of prematurity in extreme preterms

  2019cites this paper
• THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY

  2019cites this paper
• Early Postnatal IGF-1 and IGFBP-1 Blood Levels in Extremely Preterm Infants: Relationships with Indicators of Placental Insufficiency and with Systemic Inflammation

  2019cites this paper
• Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity

  2019cites this paper
• Early Total Enteral Feeding versus Conventional Enteral Feeding in Stable Very-Low-Birth-Weight Infants: A Randomised Controlled Trial

  2019cites this paper
• Relationship between severe bronchopulmonary dysplasia and severe retinopathy of prematurity in premature newborns.

  2019cites this paper
• Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity

  2019cites this paper
• Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity

  2019cites this paper
• Equivariance for deep learning and retinal imaging

  2019cites this paper
• Establishment of an abnormal vascular patterning model in the mouse retina.

  2018cites this paper
• Oxidative stress in the retina: implications for Retinopathy of Prematurity.

  2018cites this paper
• Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity

  2018cites this paper
• An Observational Cohort Study Examining the Effect of the Duration of Skin-to-Skin Contact on the Physiological Parameters of the Neonate in a Neonatal Intensive Special Care Unit

  2018cites this paper
• Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity

  2018cites this paper
• Oxygen, weight gain, IGF‐1 and ROP: not a straight‐forward equation

  2018cites this paper
• Oxygen-Induced Retinopathy from Recurrent Intermittent Hypoxia Is Not Dependent on Resolution with Room Air or Oxygen, in Neonatal Rats

  2018cites this paper
• An iTRAQ-Based Quantitative Proteomic Analysis of Plasma Proteins in Preterm Newborns With Retinopathy of Prematurity.

  2018influential citation
• Binocular Indirect Ophthalmoscopy Complements Non-contact Wide-field Imaging with Optos to Treat a Baby Outside ETROP Guidelines

  2018cites this paper
• Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy

  2018cites this paper
• Suppression of connexin 43 phosphorylation promotes astrocyte survival and vascular regeneration in proliferative retinopathy

  2018cites this paper
• Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial

  2018cites this paper
• The role of the maternal and fetal inflammatory response in retinopathy of prematurity

  2018cites this paper
• Relationship between the 5'UTR of vascular endothelial growth factor polymorphism and retinopathy of prematurity in Chinese premature newborns.

  2017cites this paper
• Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks’ gestation

  2017cites this paper
• Modern approach to the retinopathy of prematurity treatment

  2017cites this paper
• Anti-vascular endothelial growth factor treatment for retinopathy of prematurity

  2017cites this paper
• Predictors of treatment-warranted retinopathy of prematurity in the SUNDROP cohort: influence of photographic features

  2017cites this paper
• The relationship of the subtypes of preterm birth with retinopathy of prematurity

  2017cites this paper
• A predictive score for retinopathy of prematurity by using clinical risk factors and serum insulin-like growth factor-1 levels.

  2017cites this paper
• Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.

  2017cites this paper
• Retinopathy of prematurity like retinopathy in full-term infants

  2017cites this paper
• Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats.

  2016cites this paper
• Retinopathy of prematurity: the need for prevention

  2016cites this paper
• IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

  2016cites this paper
• Retinopathy of prematurity: an oxidative stress neonatal disease.

  2016influential citation
• A new role for cofilin in retinal neovascularization

  2016cites this paper
• The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II UK Trial

  2016influential citation
• An evaluation of the screening for retinopathy of prematurity in very-low-birth-weight babies at a tertiary hospital in Johannesburg, South Africa

  2016cites this paper
• Proline-rich tyrosine kinase 2 via enhancing signal transducer and activator of transcription 3-dependent cJun expression mediates retinal neovascularization

  2016cites this paper
• The Relationship of Novel Plasma Proteins in the Early Neonatal Period With Retinopathy of Prematurity

  2016influential citation
• Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease

  2015cites this paper
• Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.

  2015cites this paper
• Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy.

  2015cites this paper
• The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease

  2015cites this paper
• Laser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity

  2015cites this paper
• Retinopathy of prematurity: New developments bring concern and hope

  2015cites this paper
• A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity

  2015cites this paper
• Current understanding and management of aggressive posterior retinopathy of prematurity

  2015cites this paper
• The effect of erythropoietin on the severity of retinopathy of prematurity

  2014cites this paper